Company intelligence / Profile preview

Cancer Research Technology

London, England, United Kingdomcrtp.ccr.cancer.gov ↗

Ownership: Private
Employees: ~250
Development stage: Preclinical

Overview

Cancer Research Technology is the development and commercialization arm of Cancer Research UK, the world’s largest charitable funder of cancer research. It specializes in translating academic discoveries into new cancer therapies and has helped bring five drugs to market. Through its integration into Cancer Research Horizons, it now offers end-to-end support for drug discovery and development, including access to advanced technologies like CRISPR gene editing.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyCRISPR-based therapy
Industry: Drug Discovery Services

Partnerships

AstraZeneca (Functional Genomics Centre)Institute of Cancer Research London

Beyond the preview

Go deeper on Cancer Research Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer Research Technology.

Explore the full profile